Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy
REBIRTH - Study of Bromocriptine in Women with Peripartum Cardiomyopathy (PPCM)
Sponsor: National Cancer Institute
Enrolling: Female Patients Only
IRB Number: AAAU2889
U.S. Govt. ID: NCT05180773
Contact: Jennifer Haythe: / jhh28@cumc.columbia.edu
Additional Study Information: We are doing this study to test the use of a drug called bromocriptine for women with a condition called Peripartum cardiomyopathy (PPCM). The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill.
Investigator
Jennifer Haythe, MD
Do You Qualify?
Have you been diagnosed with peripartum cardiomyopathy? Yes No
Are you in the last month of your pregnancy or the first 5 months postpartum? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Jennifer Haythe
jhh28@cumc.columbia.edu

This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE